RLAY Relay Therapeutics 添加自选 2.810 +0.020+0.72% 收盘价 05/16 16:00 (美东) 4.82亿总市值-1.28市盈率TTM 2.900最高价2.750最低价128.31万股成交量2.800今开2.790昨收364.21万成交额0.98%换手率亏损市盈率(静)1.71亿总股本10.72052周最高0.67市净率3.68亿流通值1.77552周最低--股息TTM1.31亿流通股64.370...
Relay Therapeutics, Inc. Common Stock (RLAY) Real-Time 最新更新数据 May 22, 2025. 本页面恢复更新时间 May 27, 2025 04:00 AM ET*Today’s High/Low is only updated during regular trading hours; and does not include trades occurring in pre-market or after-hours....
Relay Therapeutics将参加即将举行的两场投资者会议 剑桥,马萨诸塞州,2025年5月8日(环球新闻通讯社)-- Relay Therapeutics, Inc.(纳斯达克:RLAY),一家临床阶段的精准医学公司,通过结合领先的药物发现过程进行转型。 GlobeNewswire05/09 04:05 市场热议龙头榜市场热议龙头榜 ...
A high-level overview of Relay Therapeutics, Inc. (RLAY) stock. View (RLAY) real-time stock price, chart, news, analysis, analyst reviews and more.
Relay Therapeutics的裁员接力赛终于按下了暂停键 环球视野,深度视角各位亲爱的股东们,大家早上好中午好晚上好。大家假期玩的开心吗?倒计时了哦。2024年10月3日,A.I.制药公司公司Relay Therapeutics 裁员10%,约30人左右。该公司发言人告诉媒体,这是本轮调整的最后一环。今年7月,该公司刚裁完约5%的员工。言下之...
Get Relay Therapeutics Inc (RLAY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Oppenheimer downgraded Relay Therapeutics to Perform from Outperform. The firm says the results from the company’s ReDiscover study were “underwhelming” with a 57% ...
547 shares of its common stock at a public offering price of $26.50 per share. Relay Therapeutics also granted the underwriters a 30-day option to purchase up to an additional 1,981,132 shares of its common stock. The gross proceeds from the offering, before deducting underwr...
Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by leveraging unparalleled insights into protein motion, today announced the pricing of its initial public offering of 20,000,000 shares of its common stock at a price to ...
RLAY | Complete Relay Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.